Evidence map

ArticleClinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico2026

PRMT5 is a prognostic-related biomarker associated with the tumor immune microenvironment in lung adenocarcinoma.

Xiaochun Xia et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 42247115